STOCK TITAN

L Catterton Announces Sale of Thorne to The Procter & Gamble Company for $3.8 Billion

(Neutral)
(Very Positive)
Tags

The Procter & Gamble Company (NYSE: PG) will acquire Thorne, a science-backed health and wellness brand, from private equity owner L Catterton under a definitive agreement valuing Thorne at $3.8 billion in cash.

L Catterton invested in Thorne in October 2023 and supported growth by upgrading leadership, marketing, R&D, manufacturing quality systems, and technology, including a proprietary AI wellness advisor. The transaction, with Perella Weinberg Partners and Canaccord Genuity advising Thorne and Jones Day advising Procter & Gamble, is expected to close in the fourth quarter of 2026, subject to customary conditions.

Loading...
Loading translation...

Positive

  • $3.8 billion cash acquisition adds established science-backed wellness brand Thorne to PG
  • Deal expected to close in Q4 2026, providing a clear near-term timeline
  • Acquisition brings Thorne’s 40-year scientific expertise and practitioner relationships into PG’s portfolio
  • PG gains access to Thorne’s proprietary AI wellness advisor and enhanced digital capabilities

Negative

  • Transaction requires $3.8 billion cash outlay from Procter & Gamble

News Market Reaction – PG

+2.10%
1 alert
+2.10% Session close to close
$334.82B Market Cap
1.1x Rel. Volume

In the Aug 4 session, PG gained 2.10%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

PG's recent record includes a +0.70% reaction to the Swiffer launch, adding historical context to th...
Analysis

PG's recent record includes a +0.70% reaction to the Swiffer launch, adding historical context to the Thorne sale. The transaction's expected fourth-quarter 2026 closing makes completion timing the primary event-specific watch item.

Key Figures

Transaction value: $3.8 billion in cash Investment date: October 2023 Company history: 40-year history +2 more
5 metrics
Transaction value $3.8 billion in cash Sale of Thorne to The Procter & Gamble Company
Investment date October 2023 L Catterton invested in Thorne
Company history 40-year history Thorne's scientific expertise and brand development
Expected closing period Fourth quarter of 2026 Expected transaction closing
Partnership duration Less than three years L Catterton's partnership with Thorne

Historical Context

5 past events · Latest: Jul 22 (Positive)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Jul 22 Product launch Positive +0.7% Swiffer introduced Lemon Dusters with scent and dust-trapping features.
Jul 16 Brand partnership Positive +2.3% Head & Shoulders activated its multi-year USA Gymnastics partnership.
Jul 14 Dividend declaration Positive +1.4% P&G declared a quarterly dividend of $1.0885 per share.
Jul 06 Marketing campaign Positive -1.4% Febreze launched a campaign with Major League Soccer and Trevor Noah.
Jul 01 Earnings webcast Neutral +0.5% P&G scheduled a webcast covering fourth-quarter fiscal 2026 earnings.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

PG's five recent news events produced four positive 24-hour reactions and one negative divergence.

Key Terms

definitive agreement
1 terms
definitive agreement regulatory
"it has signed a definitive agreement to sell Thorne"
A definitive agreement is a formal, legally binding document that outlines the final terms and conditions of a deal or transaction, such as a sale or partnership. It acts like a detailed contract that confirms all parties have agreed on the key details, making the deal official. For investors, it signals that the agreement is settled and moving toward completion, providing clarity and security about the transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

L Catterton's Deep Category Conviction and Brand Vision Allowed for Accelerated Growth and Fortified Thorne's Position as the Premier Trusted Brand in Science-Backed Wellness

GREENWICH, Conn., Aug. 4, 2026 /PRNewswire/ -- L Catterton, the largest global consumer-focused investment firm, today announced that it has signed a definitive agreement to sell Thorne, a leader in science-backed health and wellness solutions, to The Procter & Gamble Company (NYSE: PG) for $3.8 billion in cash. This follows a successful partnership that accelerated the Company's growth and further strengthened its leadership in the wellness category.

L Catterton invested in Thorne in October 2023 following years of research into the Vitamins, Minerals, and Supplements (VMS) category, recognizing an enduring shift in consumer behavior toward proactive, clinical-based products and an integrative approach to self-directed care. The firm's conviction that consumers would increasingly seek trusted solutions to support overall health and longevity led it to identify Thorne as the best-positioned brand to meet this consumer demand.

L Catterton helped accelerate Thorne's next phase of growth by recruiting an exceptional leadership team, expanding the brand's reach through enhanced marketing and commercial capabilities, further investing in science and R&D, strengthening world-class manufacturing and quality systems, and building technology and data infrastructure that enabled the Company to better serve practitioners and consumers. Given Thorne's 40-year history of scientific expertise, practitioner relationships, and consumer insights, the Company developed a proprietary AI wellness advisor that educates and enhances the consumer experience. In less than three years, the partnership further strengthened Thorne's leadership in wellness while preserving the scientific rigor and product quality that have defined the brand since its founding.

Marc Magliacano, a Managing Partner at L Catterton, said, "Our investment in Thorne reflects what L Catterton does best: identifying enduring shifts in consumer behavior and partnering with category-leading brands to help them realize their full potential. As consumers increasingly prioritize proactive, clinically-backed solutions that increase healthspan, we believed Thorne was uniquely positioned to lead the category. We are proud to have partnered with the Company during this important chapter in its growth and are confident it is well positioned for all that is ahead."

Rajan Shah, a Partner at L Catterton, added, "From the outset, we shared a long-term vision with Colin and the Thorne team to build on the brand's strong foundation and the trust it had earned with practitioners and consumers alike, while accelerating its next phase of growth. It was a privilege to partner with such an exceptional management team, and we are confident Procter & Gamble is best positioned to build on that momentum."

Colin Watts, Chief Executive Officer of Thorne, said, "L Catterton has been an outstanding partner over the past several years. They shared our long-term vision for Thorne, investing in our people, strengthening our capabilities across digital, AI, and supply chain, and advancing our scientific rigor, world-class manufacturing, quality standards, and innovation that define Thorne – all while helping us better serve healthcare practitioners and customers. I'm incredibly proud of what we've accomplished together and grateful for the role they played in helping prepare Thorne for this next chapter."

The transaction is expected to close in the fourth quarter of 2026. Perella Weinberg Partners and Canaccord Genuity LLC acted as financial advisors to Thorne, and Kirkland & Ellis served as legal advisor. Jones Day acted as legal advisor to Procter & Gamble.

About L Catterton

L Catterton is the largest global consumer-focused investment firm managing approximately $40 billion of equity capital across multiproduct platforms dedicated to private equity, credit, and real estate. The firm's funds have the ability to invest between $5 million and $5 billion, across the capital structure, in well-positioned consumer businesses. Leveraging deep category insight, operational excellence, and a broad network of strategic relationships, L Catterton's team of more than 200 investment and operating professionals across 18 offices partners with management teams to drive differentiated value creation across its portfolio. Founded in 1989, the firm has made over 300 investments in some of the world's most iconic consumer brands. For more information, please visit www.lcatterton.com.

CONTACT
Julie Hamilton
media@lcatterton.com

Cision View original content:https://www.prnewswire.com/news-releases/l-catterton-announces-sale-of-thorne-to-the-procter--gamble-company-for-3-8-billion-302842797.html

SOURCE L Catterton

FAQ

What is Procter & Gamble (PG) paying to acquire Thorne in 2026?

Procter & Gamble is paying $3.8 billion in cash to acquire Thorne. According to L Catterton, the definitive agreement values Thorne at this amount, reflecting its position in science-backed health and wellness solutions.

When is Procter & Gamble’s (PG) acquisition of Thorne expected to close?

The Thorne acquisition by Procter & Gamble is expected to close in the fourth quarter of 2026. According to L Catterton, the transaction remains subject to customary closing conditions and regulatory approvals, if any are required.

What does Thorne do and why is Procter & Gamble (PG) acquiring it?

Thorne provides science-backed health and wellness solutions, including vitamins, minerals, and supplements. According to L Catterton, Thorne combines long-standing scientific expertise, practitioner relationships, and a proprietary AI wellness advisor to serve consumers seeking proactive, clinically based wellness products.

How could Procter & Gamble’s (PG) purchase of Thorne affect its wellness portfolio?

The acquisition adds a leading science-based wellness brand to Procter & Gamble’s portfolio. According to L Catterton, Thorne brings advanced R&D, world-class manufacturing and quality systems, plus digital and AI capabilities that can broaden PG’s presence in proactive health and wellness categories.

Who advised on Procter & Gamble’s (PG) acquisition of Thorne for $3.8 billion?

Perella Weinberg Partners and Canaccord Genuity advised Thorne as financial advisors on the deal. According to L Catterton, Kirkland & Ellis served as Thorne’s legal advisor, while Jones Day acted as legal advisor to Procter & Gamble.

What role did L Catterton play before selling Thorne to Procter & Gamble (PG)?

L Catterton invested in Thorne in October 2023 and supported its growth. According to L Catterton, it enhanced leadership, marketing, R&D, manufacturing quality, and data infrastructure, helping establish Thorne as a leading trusted brand in science-backed wellness before the sale.